Description: This session reviewed the distinctions and blurring of those distinctions between group and individual life insurance. Topics include differences in underwriting, legal constraints, marketing and distribution, and the nature of guarantees provided

Description: The presenters in this classic session will explore protection and accumulation products as well discuss the current state of the hybrid Life/LTC market. They will also examine the latest trends and the challenges to innovation and highlight key factors impacting the product actuary including the impact of technology, regulation and competitive environment. 

Description: This session from the 1995 SOA Boston Meeting covers usage, sales methods, and design of COLI products and their many variations. Presenters will discuss market potential, distribution systems, risks, product features, pricing implications, and tax issues. From the Record of the Society of Actuaries, Vol. 21, No. 4b.

Description: 1999 SOA Regional Meeting, Atlanta. This session covered the process of rapid product issue and the implications that has from a marketing, underwriting, operational, product pricing, and design standpoint.

Description: Article The U.S. Government Cost Disclosure Report by Moorhead in The Actuary, June 1979, Volume 13, Number 6

Description: Read the Quo Vadis Reinsurance.

Description: This paper considers in more detail the differences between provisions necessary for nonparticipating and those necessary for participating adjustable life policies and will provide a possible means of designing nonparticipating policies that can adjust directly to future changes in mortality and interest valuation bases. A discussion of the paper follows. From Transactions of Society of Actuaries 1979, Vol 31.

Description: The presenters will share information about: -Insights into causes of death through the use of predictive models, based on a reinsured U.S. life portfolio, using logistic regression models to understand three main causes of death: cancer, heart and external causes; -Opioid abuse is a widespread phenomenon with drug-related mortality rates rising steeply in the U.S. over the past two decades. But what does the most recent data tell U.S. about the outlook for Opioid-related mortality?; -'Deaths of despair' have been publicized as a cause for the poor performance of U.S. mortality in recent years. The presenters will be looking at the different causes under this label, their evolution and explore the drivers behind them.

Description: This paper deals primarily with the actuarial aspects of a life insurance product providing complete flexibility in the pattern of premium payments- and benefits. This paper presented a framework around which a policy of the life-cycle family can be built. Discussion includes description of how the product might work, given the legal and operational constraints at the time. Also discussion of how compliance with the Standard Valuation Law and Standard Non forfeiture laws would be achieved. Followed by submitted discussions of the paper by various people

Description: This 1978 discussion focused on Adjustable Life Products. Topics included: 1. Current status in marketplace. 2. Future expectations. 3. Product design. 4. Typical riders. 5. Strengths and weaknesses. 6. Administrative requirements.